Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 17 | 5306 | 48.7 | 93% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | MICRORNA | Author keyword | 193 | 15% | 23% | 1196 |
| 2 | MIR 21 | Author keyword | 60 | 37% | 2% | 128 |
| 3 | MICRORNAS | Author keyword | 50 | 15% | 6% | 305 |
| 4 | MIR 145 | Author keyword | 49 | 54% | 1% | 64 |
| 5 | MIRNA | Author keyword | 41 | 11% | 7% | 352 |
| 6 | MIR 205 | Author keyword | 34 | 61% | 1% | 36 |
| 7 | MICRORNA 21 | Author keyword | 25 | 39% | 1% | 50 |
| 8 | MIR 375 | Author keyword | 23 | 54% | 1% | 30 |
| 9 | MIR 143 | Author keyword | 20 | 48% | 1% | 30 |
| 10 | MICRORNA 145 | Author keyword | 17 | 52% | 0% | 23 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | MICRORNA | 193 | 15% | 23% | 1196 | Search MICRORNA | Search MICRORNA |
| 2 | MIR 21 | 60 | 37% | 2% | 128 | Search MIR+21 | Search MIR+21 |
| 3 | MICRORNAS | 50 | 15% | 6% | 305 | Search MICRORNAS | Search MICRORNAS |
| 4 | MIR 145 | 49 | 54% | 1% | 64 | Search MIR+145 | Search MIR+145 |
| 5 | MIRNA | 41 | 11% | 7% | 352 | Search MIRNA | Search MIRNA |
| 6 | MIR 205 | 34 | 61% | 1% | 36 | Search MIR+205 | Search MIR+205 |
| 7 | MICRORNA 21 | 25 | 39% | 1% | 50 | Search MICRORNA+21 | Search MICRORNA+21 |
| 8 | MIR 375 | 23 | 54% | 1% | 30 | Search MIR+375 | Search MIR+375 |
| 9 | MIR 143 | 20 | 48% | 1% | 30 | Search MIR+143 | Search MIR+143 |
| 10 | MICRORNA 145 | 17 | 52% | 0% | 23 | Search MICRORNA+145 | Search MICRORNA+145 |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | MICRORNA EXPRESSION | 125 | 23% | 9% | 469 |
| 2 | BLOOD BASED MARKERS | 101 | 84% | 1% | 56 |
| 3 | MIR 21 | 101 | 47% | 3% | 160 |
| 4 | CIRCULATING MICRORNAS | 95 | 28% | 6% | 293 |
| 5 | MICRORNAS | 84 | 12% | 12% | 649 |
| 6 | MICRORNA EXPRESSION PROFILES | 56 | 46% | 2% | 90 |
| 7 | MIR 133A | 53 | 78% | 1% | 35 |
| 8 | MIR 200 FAMILY | 51 | 27% | 3% | 162 |
| 9 | AND 145 | 49 | 94% | 0% | 17 |
| 10 | SERUM MIR 21 | 49 | 94% | 0% | 17 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Circulating MicroRNA Biomarker Studies: Pitfalls and Potential Solutions | 2015 | 11 | 49 | 53% |
| Circulating miRNAs: Roles in cancer diagnosis, prognosis and therapy | 2015 | 11 | 222 | 50% |
| Clinical relevance of circulating cell-free microRNAs in cancer | 2014 | 72 | 118 | 64% |
| MicroRNAs as Potential Biomarkers in Cancer: Opportunities and Challenges | 2015 | 5 | 174 | 69% |
| A summary for molecular regulations of miRNAs in breast cancer | 2015 | 4 | 146 | 62% |
| Altered MiRNA Expression in Gastric Cancer: a Systematic Review and Meta-Analysis | 2015 | 3 | 68 | 79% |
| MicroRNAs in Cancer | 2014 | 79 | 144 | 38% |
| In vivo delivery of miRNAs for cancer therapy: Challenges and strategies | 2015 | 8 | 133 | 27% |
| Causes and consequences of microRNA dysregulation in cancer | 2009 | 986 | 68 | 56% |
| Diagnostic and prognostic value of circulating miR-21 for cancer: A systematic review and meta-analysis | 2014 | 28 | 53 | 75% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | TIANJIN LIFE SCI | 14 | 41% | 0.5% | 27 |
| 2 | WUXI ONCOL | 7 | 53% | 0.2% | 10 |
| 3 | UNIT BIOMARKERS | 6 | 100% | 0.1% | 4 |
| 4 | COMPREHENS CANC CARE | 5 | 26% | 0.3% | 17 |
| 5 | HEPATOBILIARY PANCREAT INTESTINAL DIS | 4 | 75% | 0.1% | 3 |
| 6 | HPB SURG UNIT | 4 | 25% | 0.2% | 13 |
| 7 | SHANGHAI GASTR NEOPLASMS | 3 | 22% | 0.2% | 13 |
| 8 | CARDIOTHRORAC SURG | 3 | 100% | 0.1% | 3 |
| 9 | DIAGNOST PRODUCT DEV | 3 | 100% | 0.1% | 3 |
| 10 | ENDOCRINE ONCOL CLIN | 3 | 100% | 0.1% | 3 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000273501 | MIR 34A//MICRORNA 34A//MIR 34 |
| 2 | 0.0000264889 | NEUROTRAUMA VARIAT REGENERAT//TIANTAN HOSP//OTORHINOLARYNGOL MAXILLO IAL ONCOL |
| 3 | 0.0000258408 | DICER//DROSHA//MICROPROCESSOR COMPLEX |
| 4 | 0.0000213799 | MIR 122//MICRORNA 122//MIR 224 |
| 5 | 0.0000186586 | MIR 196A2//RS2910164//RS11614913 |
| 6 | 0.0000165342 | MIR 210//MICRORNA 210//C19MC |
| 7 | 0.0000138932 | GW182//DROSHA//ARGONAUTE |
| 8 | 0.0000135022 | MIR 155//MIR 146A//MIRNA 155 |
| 9 | 0.0000114227 | PDCD4//PROGRAMMED CELL DEATH 4//PROGRAMMED CELL DEATH 4 PDCD4 |
| 10 | 0.0000092497 | PHARMACOEPIGENETICS//ALFRED MED EDUC PROJECT//BANDUNG HOSP |